Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
TuHURA Biosciences ( (HURA) ) just unveiled an update.
TuHURA Biosciences, Inc. has announced significant salary increases for its CEO, James A. Bianco, and CFO, Dan Dearborn, effective from January 2025, aligning their compensation with industry standards. Additionally, both executives received stock option awards as part of the 2024 Equity Incentive Plan, offering potential long-term gains tied to the company’s stock performance, with the options vesting over three years.
See more insights into HURA stock on TipRanks’ Stock Analysis page.
